Ambarii Trade Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Ambarii Trade General Information
Description
Developer of cannabinoid or pterostilbene edible tablet intended to produce the pterostilbene or cannabidiol (CBD) rapid melt edible tablet. The company's cannabinoid or pterostilbene edible tablet is based on zero-sugar tablet formula and form factor enabling the patients to bring improvement in taste, rapidity of onset and strength of effect due to greater bioavailability, as had been originally hypothesized.
Contact Information
Corporate Office
- Vancouver, British Columbia
- Canada
Corporate Office
- Vancouver, British Columbia
- Canada
Ambarii Trade Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ambarii Trade Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ambarii Trade FAQs
-
When was Ambarii Trade founded?
Ambarii Trade was founded in 2017.
-
Where is Ambarii Trade headquartered?
Ambarii Trade is headquartered in Vancouver, Canada.
-
What industry is Ambarii Trade in?
Ambarii Trade’s primary industry is Drug Discovery.
-
Is Ambarii Trade a private or public company?
Ambarii Trade is a Private company.
-
What is Ambarii Trade’s current revenue?
The current revenue for Ambarii Trade is .
-
Who are Ambarii Trade’s investors?
Lexaria Bioscience and Neutrisci International have invested in Ambarii Trade.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process